FDA OKs CardioDynamics third-generation heart monitor:
This article was originally published in Clinica
Executive Summary
The US FDA has given CardioDynamics 510(k) clearance to market its third-generation impedance cardiography (ICG)-based product for monitoring the heart in a noninvasive fashion. The BioZ Dx system represents the first phase of a co-development partnership between the San Diego, California company and Philips Medical Systems; following its immediate release into the market, BioZ Dx will be upgradeable to include Philips' 12-lead ECG technology in late 2005.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.